Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 5
1974 2
1975 5
1976 4
1977 3
1978 7
1979 12
1980 7
1981 8
1982 13
1983 13
1984 8
1985 11
1986 8
1987 20
1988 10
1989 9
1990 12
1991 8
1992 12
1993 8
1994 15
1995 6
1996 9
1997 14
1998 9
1999 10
2000 7
2001 15
2002 8
2003 8
2004 9
2005 10
2006 10
2007 20
2008 26
2009 25
2010 18
2011 19
2012 14
2013 20
2014 23
2015 10
2016 6
2017 9
2018 9
2019 4
2020 7
2021 2
2022 9
2023 6
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

504 results

Results by year

Filters applied: . Clear all
Page 1
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.
Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Buyyounouski MK, Chan K, Chang SS, Chang P, Friedlander T, Greenberg RE, Guru KA, Herr HW, Hoffman-Censits J, Kaimakliotis H, Kishan AU, Kundu S, Lele SM, Mamtani R, Mian OY, Michalski J, Montgomery JS, Parikh M, Patterson A, Peyton C, Plimack ER, Preston MA, Richards K, Sexton WJ, Siefker-Radtke AO, Stewart T, Sundi D, Tollefson M, Tward J, Wright JL, Cassara CJ, Gurski LA. Flaig TW, et al. Among authors: herr hw. J Natl Compr Canc Netw. 2024 May;22(4):216-225. doi: 10.6004/jnccn.2024.0024. J Natl Compr Canc Netw. 2024. PMID: 38754471
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.
Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Chan K, Chang S, Friedlander T, Greenberg RE, Guru KA, Herr HW, Hoffman-Censits J, Kishan A, Kundu S, Lele SM, Mamtani R, Margulis V, Mian OY, Michalski J, Montgomery JS, Nandagopal L, Pagliaro LC, Parikh M, Patterson A, Plimack ER, Pohar KS, Preston MA, Richards K, Sexton WJ, Siefker-Radtke AO, Tollefson M, Tward J, Wright JL, Dwyer MA, Cassara CJ, Gurski LA. Flaig TW, et al. Among authors: herr hw. J Natl Compr Canc Netw. 2022 Aug;20(8):866-878. doi: 10.6004/jnccn.2022.0041. J Natl Compr Canc Netw. 2022. PMID: 35948037
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.
Coleman JA, Yip W, Wong NC, Sjoberg DD, Bochner BH, Dalbagni G, Donat SM, Herr HW, Cha EK, Donahue TF, Pietzak EJ, Hakimi AA, Kim K, Al-Ahmadie HA, Vargas HA, Alvim RG, Ghafoor S, Benfante NE, Meraney AM, Shichman SJ, Kamradt JM, Nair SG, Baccala AA Jr, Palyca P, Lash BW, Rizvi MA, Swanson SK, Muina AF, Apolo AB, Iyer G, Rosenberg JE, Teo MY, Bajorin DF. Coleman JA, et al. Among authors: herr hw. J Clin Oncol. 2023 Mar 10;41(8):1618-1625. doi: 10.1200/JCO.22.00763. Epub 2023 Jan 5. J Clin Oncol. 2023. PMID: 36603175 Free PMC article. Clinical Trial.
Bladder cancer.
Montie JE, Clark PE, Eisenberger MA, El-Galley R, Greenberg RE, Herr HW, Hudes GR, Kuban DA, Kuzel TM, Lange PH, Lele SM, Michalski J, Patterson A, Pohar KS, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Walther PJ, Wilson TG; National Comprehensive Cancer Network. Montie JE, et al. Among authors: herr hw. J Natl Compr Canc Netw. 2009 Jan;7(1):8-39. doi: 10.6004/jnccn.2009.0002. J Natl Compr Canc Netw. 2009. PMID: 19176203 No abstract available.
Reply by Authors.
Clements MB, Beech BB, Atkinson TM, Dalbagni GM, Li Y, Vickers AJ, Herr HW, Donat SM, Sjoberg DD, Tin AL, Coleman JA, Rapkin BD, Laudone VP, Bochner BH. Clements MB, et al. Among authors: herr hw. J Urol. 2023 May;209(5):910. doi: 10.1097/JU.0000000000003201.02. Epub 2023 Mar 6. J Urol. 2023. PMID: 36876406 No abstract available.
Bladder cancer.
Clark PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Spiess PE, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M; National Comprehensive Cancer Network (NCCN). Clark PE, et al. Among authors: herr hw. J Natl Compr Canc Netw. 2013 Apr 1;11(4):446-75. doi: 10.6004/jnccn.2013.0059. J Natl Compr Canc Netw. 2013. PMID: 23584347
Legends in urology.
Herr HW. Herr HW. Can J Urol. 2010 Feb;17(1):4972-4. Can J Urol. 2010. PMID: 20156375 Free article. No abstract available.
Goat glands rejuvenated.
Herr HW. Herr HW. BJU Int. 2009 Jul;104(1):2-4. doi: 10.1111/j.1464-410X.2009.08430.x. Epub 2009 Feb 23. BJU Int. 2009. PMID: 19239446 No abstract available.
Management of teratoma.
Herr HW, LaQuaglia MP. Herr HW, et al. Urol Clin North Am. 1993 Feb;20(1):145-52. Urol Clin North Am. 1993. PMID: 8434433 Review.
Should we abandon the FISH test?
Nieder AM, Soloway MS, Herr HW. Nieder AM, et al. Among authors: herr hw. Eur Urol. 2007 Jun;51(6):1469-71. doi: 10.1016/j.eururo.2007.01.044. Epub 2007 Jan 18. Eur Urol. 2007. PMID: 17257740 No abstract available.
504 results